A report from China showed that PD-1 expression was seen in 33.8% of the peripheral CD3-positive lymphocytes in patients with previously untreated de novo AML and was correlated with the increased expression of exhaustion markers such as CD244 and CD57 [20]. The gene discussed is PDCD1; the disease is acute myeloid leukemia.